Author Question: Which condition would be treated with therapeutic hypothermia? a. Malnutrition b. Hypothyroidism ... (Read 80 times)

karlynnae

  • Hero Member
  • *****
  • Posts: 599
Which condition would be treated with therapeutic hypothermia?
 
  a. Malnutrition
  b. Hypothyroidism
  c. Reimplantation surgery
  d. Parkinson disease

Question 2

A patient received a prescription for a weight loss pill. One effect of the pills is to increase the release of epinephrine. Which of the following would be expected to also occur?
 
  a. Decreased vascular tone
  b. Increased skeletal muscle tone
  c. Increased heat production
  d. Decreased basal metabolic rate



bpool94

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

ANS: C
Therapeutic hypothermia is seen with reimplantation surgery, not malnutrition, hypothyroidism, or Parkinson disease.

Answer to Question 2

ANS: C
Epinephrine causes vasoconstriction, stimulates glycolysis, and increases metabolic rate, thus in-creasing secondary heat production. Epinephrine does not lead to decreased vascular tone or in-creased skeletal muscle tone but does increase metabolic rate.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library